What antibiotics are safe to use in patients with stage 4 Chronic Kidney Disease (CKD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Patients with stage 4 Chronic Kidney Disease (CKD) can safely use certain antibiotics with appropriate dose adjustments to prevent toxicity. The most recent and highest quality study 1 provides guidance on antibiotic use in patients with CKD. Safe options include:

  • Macrolides like azithromycin, which require no dose adjustment as they are primarily eliminated through the liver.
  • Cephalosporins such as cefazolin and ceftriaxone, which can be used with reduced dosing (e.g., cefazolin at 1g every 24 hours instead of every 8 hours).
  • Penicillins like amoxicillin, which should be dosed at 250-500mg every 12-24 hours rather than the standard 8-hour interval.
  • Fluoroquinolones such as levofloxacin, which require significant reduction (250-500mg every 48 hours).
  • Vancomycin, which can be used but requires careful monitoring with trough levels and extended dosing intervals (15mg/kg every 3-7 days). Antibiotics to avoid or use with extreme caution include:
  • Aminoglycosides (gentamicin, tobramycin), which are nephrotoxic.
  • Nitrofurantoin, which is contraindicated in CKD stage 4. The kidney's reduced filtration capacity in stage 4 CKD (GFR 15-29 mL/min) means drugs eliminated renally accumulate, potentially causing toxicity, while also potentially reducing efficacy of some antimicrobials that require renal activation. Consultation with a pharmacist for precise dosing based on the patient's exact GFR is always recommended. Some key points to consider when choosing antibiotics for patients with stage 4 CKD include:
  • Avoiding nephrotoxic drugs
  • Adjusting doses based on renal function
  • Monitoring for signs of toxicity
  • Considering alternative antibiotics when necessary
  • Consulting with a pharmacist or nephrologist for guidance on antibiotic use in patients with CKD.

From the Research

Antibiotics Safe in Stage 4 CKD

The following antibiotics can be used in patients with stage 4 Chronic Kidney Disease (CKD), but it is essential to note that dose adjustments are often necessary to avoid accumulation and toxicity:

  • Cephalosporins: commonly used, but dose adjustment is required based on the glomerular filtration rate (GFR) 2
  • Penicillins: widely used, but 39.8% of patients received them without renal dose adjustments, highlighting the need for careful dosing 3
  • Glycopeptides: may not require dose adjustment in some cases, but caution is advised due to potential nephrotoxicity 2

Dose Adjustment Considerations

When prescribing antibiotics to patients with stage 4 CKD, it is crucial to consider the following:

  • Dose adjustment according to the GFR to prevent toxicity and ensure efficacy 2, 4
  • Use of online resources, such as Lexicomp or SiteGPR, to guide dose adjustments and ensure appropriate prescribing 2, 4, 3
  • Collaboration with clinical pharmacists and nephrologists to optimize antibiotic dosing and minimize the risk of adverse effects 3

Specific Antibiotics and CKD

Some antibiotics may require special consideration in patients with stage 4 CKD:

  • Ceftolozane/tazobactam, ceftazidime/avibactam, and telavancin: may carry precautionary statements for reduced clinical response in patients with baseline creatinine clearance of 30-50 mL/min, potentially due to unnecessary dose reduction in the setting of acute kidney injury (AKI) 5
  • Piperacillin/tazobactam: frequently prescribed without renal dose adjustment, highlighting the need for careful dosing and monitoring 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Renal Dosing of Antibiotics: Are We Jumping the Gun?

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.